Search results
Results from the WOW.Com Content Network
CAP is diagnosed by assessing symptoms, performing a physical examination, by x-ray or by sputum examination. Patients with CAP sometimes require hospitalization, and it is treated primarily with antibiotics, antipyretics and cough medicine. [2] Some forms of CAP can be prevented by vaccination [3] and by abstaining from tobacco products. [4]
Community-acquired pneumonia (CAP) is infectious pneumonia in a person who has not recently been hospitalized. CAP is the most common type of pneumonia. The most common causes of CAP vary depending on a person's age, but they include Streptococcus pneumoniae, viruses, the atypical bacteria, and Haemophilus influenzae.
The following list encompasses notable medicine contamination and adulteration incidents. 1937 Elixir sulfanilamide incident: S. E. Massengill Company used diethylene glycol as the solvent for the antibacterial sulfanilamide, leading to the 1938 passage of the Federal Food, Drug, and Cosmetic Act. [2] [3]
The examples are chitosan and gelatin, which has been used with injectable bone grafting paste. MTA Plus is used with gelatin complex as antiwashout agent. MTA Angelus Fillapex sealer contains less than 20% tri/dicalcium silicate powder in a salicylate carrier medium similar to Sealapex.
Cellulose acetate phthalate (CAP), also known as cellacefate and cellulosi acetas phthalas, is a commonly used polymer phthalate in the formulation of pharmaceuticals, such as the enteric coating of tablets or capsules and for controlled release formulations.
cap., caps. capsula: capsule cap. capiat: let him take (let the patient take) c.m. cras mane: tomorrow morning c.m.s. cras mane sumendus: to be taken tomorrow morning c̄, c. cum: with (usually written with a bar on top of the c) cib. cibus: food c.c. cum cibo: with food [or] cubic centimetre
Is one of the most commonly used tocolytic agents. [25] Hypotension, preload-dependent cardiac disease. [26] It should not be used concomitantly with magnesium sulfate [27] Flushing, headache, dizziness, nausea, transient hypotension. Administration of calcium channel blockers should be used with care in patients with renal disease and hypotension.
The attachment of these capping/stabilizing agents slows and eventually stops the growth of the particle. [5] The most common capping ligands are trisodium citrate and polyvinylpyrrolidone (PVP), but many others are also used in varying conditions to synthesize particles with particular sizes, shapes, and surface properties.